Read + Share
Amedeo Smart
Independent Medical Education
Zhai X, Shen N, Guo T, Wang J, et al. SPTLC2 drives an EGFR-FAK-HBEGF signaling axis to promote ovarian cancer progression. Oncogene 2024 Dec 7. doi: 10.1038/s41388-024-03249.PMID: 39645550
Email
LinkedIn
Privacy Policy